The Clinical Impact of Seropositivity on Treatment Response in Patients with Rheumatoid Arthritis Treated with Etanercept: A Real-World Iraqi Experience

PURPOSE: To assess the clinical impact of rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibody (ACPA)’s seropositivity on treatment response in patients with rheumatoid arthritis (RA) treated with etanercept. PATIENTS AND METHODS: A retrospective analysis of patients with RA registe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ridha, Asal, Hussein, Saba, AlJabban, Ali, Gunay, Levent Mert, Gorial, Faiq I, Al Ani, Nizar Abdulateef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215842/
https://www.ncbi.nlm.nih.gov/pubmed/35756976
http://dx.doi.org/10.2147/OARRR.S368190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215842/
https://www.ncbi.nlm.nih.gov/pubmed/35756976
http://dx.doi.org/10.2147/OARRR.S368190

Ejemplares similares